Logo image
Characterization of a TP53 Somatic Variant of Unknown Function From an Ovarian Cancer Patient Using Organoid Culture and Computational Modeling
Journal article   Peer reviewed

Characterization of a TP53 Somatic Variant of Unknown Function From an Ovarian Cancer Patient Using Organoid Culture and Computational Modeling

Jianling Bi, Kristina W Thiel, Jacob M Litman, Yuping Zhang, Eric J Devor, Andreea M Newtson, Michael J Schnieders, Jesus Gonzalez Bosquet and Kimberly K Leslie
Clinical obstetrics and gynecology, Vol.63(1), pp.109-119
03/2020
DOI: 10.1097/GRF.0000000000000516
PMCID: PMC7521672
PMID: 31876640

View Online

Abstract

In our proof-of-concept study of 1 patient with stage IIIC carcinosarcoma of the ovary, we discovered a rare mutation in the tumor suppressor, TP53, that results in the deletion of N131. Immunofluorescence imaging of the organoid culture revealed hyperstaining of p53 protein. Computational modeling suggests this residue is important for maintaining protein conformation. Drug screening identified the combination of a proteasome inhibitor with a histone deacetylase inhibitor as the most effective treatment. These data provide evidence for the successful culture of a patient tumor and analysis of drug response ex vivo.
Carcinoma, Ovarian Epithelial - genetics Female Genetic Predisposition to Disease Humans Organoids - metabolism Ovarian Neoplasms - genetics Patient-Specific Modeling Tumor Suppressor Protein p53 - genetics

Details

Metrics

Logo image